T/FIF, a New Plateau Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (930)	2/6/2002 2:01:51 AM
From: Spekulatius	of 2243

<<Well, they're going to get bids. >> I sure hope so.I never invested in ELN because earnings were overstated through capitalized R&D expenses (this is what these joint ventures were created for). However,it appears to me that these JV's are no shams. ELN has developed real products, using the biotechs JV. its funny, that the JV business model was "approved" for years and years and now gets flamed because of "Enronitis". At a little more than 2x revenues, ELN's market cap is now very low, compared to slower growth pharma (5x revenues). Good or bad accounting, ELN has real drugs in the market and real drugs in the pipeline and smart investors or a smart pharma CEO will recognize this. I own a few ELN shares now.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next